Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study

NCT04888793 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT04888793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Observational
Overall status
Completed
Start date
May 12, 2021
Completion date
November 1, 2021
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines, covid19